Dr. Stevens is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6701 Fannin St
Houston, TX 77030Phone+1 832-824-1000Fax+1 832-825-1206
Education & Training
- Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 2010 - 2013
- Icahn School of Medicine at Mount Sinai/Kravis Children'sResidency, Pediatrics, 2007 - 2010
- Columbia University Vagelos College of Physicians and SurgeonsClass of 2007
Certifications & Licensure
- TX State Medical License 2013 - 2025
- NY State Medical License 2008 - 2011
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Atovaquone (Mepron®) Combined With Conventional Chemotherapy for de Novo Acute Myeloid Leukemia (AML) Start of enrollment: 2018 Jul 10
Publications & Presentations
PubMed
- 1 citationsImplementation of a light therapy team to administer photobiomodulation therapy: A standardized protocol to prevent and treat oral mucositis in the pediatric hematopoi...Kathleen Magee, Jenell Robins, Sharon Staton, Gabriella Llaurador, Alexandra M Stevens
Pediatric Blood & Cancer. 2024-06-01 - 1 citationsAddressing a Pre-Clinical Pipeline Gap: Development of the Pediatric Acute Myeloid Leukemia Patient-Derived Xenograft Program at Texas Children's Hospital at Baylor Co...Alexandra M Stevens, Maci Terrell, Raushan Rashid, Kevin E Fisher, Andrea N Marcogliese
Biomedicines. 2024-02-08 - Levofloxacin prophylaxis for pediatric leukemia patients: monitoring of outcomes for sustained benefit and consequences.Andrea L Davis, Alexandra M Stevens, Julienne Brackett, Lucila Marquez, Catherine E Foster
Antimicrobial Stewardship & Healthcare Epidemiology. 2024-01-01
Abstracts/Posters
- Enhancing the Effect of CLL-1 CAR T Cells with Interleukin-15 for Treatment of Acute Myeloid LeukemiaAlexandra McLean Stevens, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Rara Is a Druggable Super-Enhancer Regulated Dependency in Pediatric AMLAlexandra McLean Stevens, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
- Notable Presents Clinical Validation Data from Two Phase 2 Trials in Adult and Pediatric Acute Myelogenous Leukemia at the 63rd American Society of Hematology (ASH) Annual MeetingDecember 16th, 2021
- The Eye of a SurvivorAugust 2nd, 2021
- Honors and GradsJune 29th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: